OHSU in the news

GRAIL presents interventional PATHFINDER study data at 2021 ASCO annual meeting and introduces Galleri, a groundbreaking multi-cancer early detection blood test

The Associated Press June 04, 2021
An international study led at OHSU by Tomasz Beer, M.D., establishes a new therapy for men with prostate cancer that has spread and become resistant to hormone therapy: "This is a completely new treatment option that extends life and disease control in metastatic castration-resistant prostate cancer –- the most aggressive and deadly type."

CRISPR study is first to change DNA in participants

Healthline June 02, 2021
In early 2020, OHSU Casey Eye Institute faculty performed the first CRISPR gene editing procedure inside the human body for a clinical trial evaluating an investigational treatment for a blindness-causing genetic mutation.

OHSU project seeks to increase HPV vaccinations

Columbia County Spotlight June 02, 2021
OHSU Family Medicine Scappoose is working to boost immunization rates among kids — particularly for the human papilloma virus vaccine — through the Rural Adolescent Vaccine Enterprise project.

Pride in the workplace

Portland Business Journal June 02, 2021
In an article on how to build a safe, affirming work environment for all, Amy Penkin discusses how OHSU's Transgender Health Program is managing increasing demand for gender-affirming services.
See more stories